|
John Whittall, PhD, works at the Centre of Excellence for Biocatalysis, Biotransformations and Biocatalytic Manufacture (CoEBio3), Manchester Institute of Biotechnology, University of Manchester, UK. Peter W. Sutton, PhD, was Scientific Investigator, GlaxoSmithKline Research and Development Limited, UK, now R&D Director at GlycoScience S.L., Barcelona, Spain.
|